Related Experiment Video
Updated: Feb 9, 2026

Investigating Migraine-Like Behavior Using Light Aversion in Mice
Published on: August 11, 2021
Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in mice
Shayne N Hassler1, Fatima B Ahmad1, Carolina C Burgos-Vega1
11 School of Brain and Behavioral Sciences, University of Texas at Dallas, TX, USA.
Background:
Pain is the most debilitating symptom of migraine. The cause of migraine pain likely requires activation of meningeal nociceptors. Mast cell degranulation, with subsequent meningeal nociceptor activation, has been implicated in migraine pathophysiology. Degranulating mast cells release serine proteases that can cleave and activate protease activated receptors. The purpose of these studies was to investigate whether protease activated receptor 2 is a potential generator of nociceptive input from the meninges by using selective pharmacological agents and knockout mice.
Methods:
Ratiometric Ca++ imaging was performed on primary trigeminal and dural cell cultures after application of 2at-LIGRL-NH2, a specific protease activated receptor 2 agonist. Cutaneous hypersensitivity and facial grimace was measured in wild-type and protease activated receptor 2-/- mice after dural application of 2at-LIGRL-NH2 or compound 48-80, a mast cell degranulator. Behavioral experiments were also conducted in mice after dural application of 2at-LIGRL-NH2 (2AT) in the presence of either C391, a selective protease activated receptor 2 antagonist, or sumatriptan.
Results:
2at-LIGRL-NH2 evoked Ca2+ signaling in mouse trigeminal neurons, dural fibroblasts and in meningeal afferents. Dural application of 2at-LIGRL-NH2 or 48-80 caused dose-dependent grimace behavior and mechanical allodynia that were attenuated by either local or systemic application of C391 as well as in protease activated receptor 2-/- mice. Nociceptive behavior after dural injection of 2at-LIGRL-NH2 was also attenuated by sumatriptan.
Conclusions:
Functional protease activated receptor 2 receptors are expressed on both dural afferents and fibroblasts and activation of dural protease activated receptor 2 produces migraine-like behavioral responses. Protease activated receptor 2 may link resident immune cells to meningeal nociceptor activation, driving migraine-like pain and implicating protease activated receptor 2 as a therapeutic target for migraine in humans.
Insights
Protease activated receptor 2 (PAR2) activation in the meninges triggers migraine-like pain by stimulating nociceptors. Blocking PAR2 or using sumatriptan alleviates this pain, suggesting PAR2 is a potential therapeutic target for migraines.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Migraine pain is often caused by activated meningeal nociceptors.
- Mast cell degranulation is implicated in migraine pathophysiology, releasing proteases that activate protease-activated receptors (PARs).
Purpose of the Study:
- To investigate if protease activated receptor 2 (PAR2) generates nociceptive input from the meninges.
- To explore PAR2's role in migraine pathophysiology using pharmacological agents and knockout mice.
Main Methods:
- Primary trigeminal and dural cell cultures underwent calcium imaging after exposure to a PAR2 agonist (2at-LIGRL-NH2).
- Wild-type and PAR2 knockout mice were assessed for hypersensitivity and grimace behavior after dural application of 2at-LIGRL-NH2 or a mast cell degranulator (compound 48-80).
- Behavioral experiments included administering a PAR2 antagonist (C391) or sumatriptan.
Main Results:
- 2at-LIGRL-NH2 induced calcium signaling in trigeminal neurons, dural fibroblasts, and meningeal afferents.
- Dural application of 2at-LIGRL-NH2 or compound 48-80 caused dose-dependent grimace behavior and mechanical allodynia.
- These migraine-like responses were attenuated by the PAR2 antagonist C391 and in PAR2 knockout mice, and also by sumatriptan.
Conclusions:
- Functional PAR2 receptors are present on dural afferents and fibroblasts.
- Activation of dural PAR2 elicits migraine-like behavioral responses.
- PAR2 may link immune cells to meningeal nociceptor activation, driving migraine pain and representing a potential therapeutic target.
Related Concept Videos
Co-activators and Co-repressors
tRNA Activation
Activation Energy
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Secondary Active Transport
Primary Active Transport

